BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Identify Transformative ALS Targets\, Seek Translational Bioma
 rkers and Propel More Clinical Approvals\n\nFollowing monumental progress
  in 2023\, the ALS treatment landscape is surging with novel innovation t
 o navigate the complex\, multifactorial nature of motor neuron degenerati
 on and develop more truly transformative drugs for sporadic and familial 
 ALS.\n\nCapitalizing on rapid pipeline progress and emerging industry inv
 estment\, the 3rd Annual ALS Drug Development Summit returns to Boston\, 
 providing a comprehensive breakdown of the latest motor neuron models\, b
 iomarker strategies\, approval insights\, and novel approaches to target 
 the likes of TDP-43\, STMN2\, and PIKfyve. Engage in forward-thinking dis
 cussions and gain fresh perspectives on the most meaningful endpoints and
  trial design considerations for people living with ALS.\n\nThis May\, jo
 in your industry colleagues across discovery\, preclinical\, clinical\, r
 egulatory\, and commercial from the likes of Biogen\, Amylyx\, AbbVie\, N
 euroSense\, Mitsubishi\, Sanofi\, Takeda\, Novartis\, and more.\n\nDate a
 nd Time: Tuesday\, 21 May 2024 at 08:00 to Thursday\, 23 May 2024 at 17:0
 0\n
DTEND:20240523T170000
DTSTAMP:20260512T220338Z
DTSTART:20240521T080000
LOCATION:Hyatt Regency Boston\, 1 Avenue de Lafayette\, Boston\, Massachus
 etts\, 02111\,
SEQUENCE:0
SUMMARY:Identify Transformative ALS Targets\, Seek Translational Biomarker
 s and Propel More Clinical Approvals\nFollowing monumental progress in 20
 23\, the A...
UID:e773578c-9fc0-471c-9cb2-38e1c57457cd
END:VEVENT
END:VCALENDAR